ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,567.80
(
0.38%
)
US Tech 100
15,543.60
(
-0.31%
)
Dow Jones
35,950.89
(
1.47%
)
Brent Oil
80.575
(
-2.53%
)
Bitcoin
37,732.75
(
-0.36%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) News

TTNP Titan Pharmaceuticals Inc

0.340201
0.008 (2.41%)
After Hours
Last Updated: 16:12:40
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.008 2.41% 0.340201 16:12:40
Open Price Low Price High Price Close Price Prev Close
0.34 0.34 0.35 0.340201 0.3322
more quote information »

Recent News

Date Time Source Heading
11/28/202316:47EDGAR2Form DEF 14A - Other definitive proxy statements
11/17/202316:03EDGAR2Form PRE 14A - Other preliminary proxy statements
11/15/202316:05EDGAR2Form 8-K - Current report
10/26/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202317:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/23/202315:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/16/202317:08EDGAR2Form 8-K - Current report
10/16/202316:37GLOBETitan Pharmaceuticals Announces Appointment of Dato' Seow..
10/04/202317:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
9/19/202316:41EDGAR2Form 8-K/A - Current report: [Amend]
9/18/202316:45EDGAR2Form 8-K - Current report
9/18/202307:30GLOBETitan Pharmaceuticals Announces $9.5 Million Private..
9/08/202317:30EDGAR2Form 8-K - Current report
8/30/202316:28EDGAR2Form 8-K - Current report
8/14/202317:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/31/202319:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/31/202319:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/28/202317:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/28/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/28/202317:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/28/202317:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/27/202307:30GLOBETitan Pharmaceuticals Announces Sale of Certain ProNeura..
7/20/202321:57EDGAR2Form SC 13D - General statement of acquisition of beneficial..
7/07/202310:28EDGAR2Form 8-K - Current report
6/29/202316:15EDGAR2Form 8-K - Current report
12/15/202207:00GLOBETitan Pharmaceuticals Provides Shareholder Update
12/12/202207:49GLOBEUPDATE -- Titan Pharmaceuticals Inc. Announces Licensing..

Your Recent History

NASDAQ
TTNP
Titan Pharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com